SP-D is a likely marker for lung diseases because disease-induced breakdown or changes enhance its systemic leaking from the lungs, so disturbances in SP-D was reported in several neonatal diseases including lung infections, RDS, and bronchopulmonary dysplasia [37–39]. This evidence concerns the gene SFTPD and newborn respiratory distress syndrome.